The American Journal of Managed Care1 天
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...
Business Wire2 天
CareDx宣布一项研究表明AlloSeq cfDNA在检测器官移植患者的排斥反应方面 ...
(美国商业资讯)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant ...